Cryptoccocal meningitis in Yaoundé (Cameroon) HIV infected patients: Diagnosis, frequency and Cryptococcus neoformans isolates susceptibility study to fluconazole

Journal de Mycologie Medicale

Volumn 25, Issue 1, 2015, Pages 11-16

  Kammalac Ngouana, T ^a,c,d   Dongtsa, J ^a   Kouanfack, C ^a,c   Tonfack, C ^a   Fomena, S ^b   Mallie M ^c   Delaporte, E ^c   Boyom, F Fekam ^d   Bertout, S ^c  

^a YAOUNDÉ CENTRAL HOSPITAL   (Cameroon)

^b National Institute of Statistics   (Cameroon)

^c INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (France)

^d UNIVERSITY OF YAOUNDÉ I   (Cameroon)

Author keywords

Cryptococcosis; Diagnosis; Fluconazole; Frequency; HIV infection

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE; GLUCOSE; PROTEIN; ANTIFUNGAL AGENT;

ADULT; AGED; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; CAMEROON; CEREBROSPINAL FLUID ANALYSIS; CRYPTOCOCCAL MENINGITIS; CRYPTOCOCCUS NEOFORMANS; CYTOCHEMISTRY; DISEASE CLASSIFICATION; FEMALE; FUNGAL STRAIN; FUNGUS ISOLATION; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; LATEX AGGLUTINATION TEST; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; PROTEIN BLOOD LEVEL; SENSITIVITY AND SPECIFICITY; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANIMAL; ANTIFUNGAL RESISTANCE; BIRD; CEREBROSPINAL FLUID; DRUG EFFECTS; HIV INFECTIONS; ISOLATION AND PURIFICATION; MENINGITIS, CRYPTOCOCCAL; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MIDDLE AGED;

FILOBASIDIELLA NEOFORMANS;

ADULT; AGED; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANIMALS; ANTIFUNGAL AGENTS; BIRDS; CAMEROON; CRYPTOCOCCUS NEOFORMANS; DRUG RESISTANCE, FUNGAL; FEMALE; FLUCONAZOLE; HIV INFECTIONS; HUMANS; MALE; MENINGITIS, CRYPTOCOCCAL; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED;

EID: 84924300075     PISSN: 11565233     EISSN: 17730449     Source Type: Journal    
DOI: 10.1016/j.mycmed.2014.10.016     Document Type: Article

References (40)

1. Aberg J.A., Powderly W.G. Cryptococcosis and HIV. HIV in site know. Base chapter 2006, New York University, New York.
2. Aller A.I., Martin-Mazuelos E., Lozano F., Gomez-Mateos J., Steele-Moore L., Holloway W.J., et al. Correlation of fluconazole MICs with clinical outcome in cryptococcal infection. Antimicr Ag Chemother 2000, 44:1544-1548.
3. Arechavala A.I., Ochiuzzi M.E., Borgnia M.D., Santiso G.M. Fluconazole and amphotericin B susceptibility testing of Cryptococcus neoformans: Results of minimal inhibitory concentrations against 265 isolates from HIV-positive patients before and after two or more months of antifungal therapy. Rev Iberoam Micol 2009, 26(3):194-197.
4. Bertout S., Drakulovski P., Kouanfack C., Krasteva D., Ngouana T., Dunyach-Remy, et al. Genotyping and antifungal susceptibility testing of Cryptococcus neoformans isolates from Cameroonian HIV-positive adult patients. Clin Microbiol Infect 2013, 19:763-769. 10.1111/1469-0691.12019.
5. Bicanic T., Harrison T., Niepieklo A., Nontobeko D., Graeme M. Symptomatic relapse of HIV-associated cryptococcal meningitis after initial fluconazole monotherapy the role of fluconazole resistance and immune reconstitution. Clin Infect Dis 2006, 43:1069-1073.
6. Bissagnene E., Ouhon J., Kra O., Kadio A. Aspects actuels de la cryptococcose neuroméningée à Abidjan. Med Mal Infect 1994, 24:580-585.
7. Blevins L.B., Fenn J., Segal H., Newcomb-Gayman P., Carroll K.C. False-positive cryptococcal antigen latex agglutination caused by disinfectants and soaps. J Clin Microbiol 1995, 33:1674-1675.
8. Busari O., Adeyemi A., Agboola S. Cryptococcal meningitis in AIDS. Int J of Inf Dis 2009, 7. http://www.ispub.com/jourmal/ijid/v7n1.
9. Chayakulkeeree M., Perfect J.R. Cryptococcosis. Infect Dis Clin North Am 2006, 20:507-544.
10. Currie B.P., Freundlich L.F., Soto M.A., Casadevall A. False-negative cerebrospinal fluid cryptococcal latex agglutination tests for patients with culture-positive cryptococcal meningitis. J Clin Microbiol 1993, 31:2519-2522.
11. Darras-Joly C., Chevret S., Wolff M., Matheron S., Longuet P., Casalino E., et al. Cryptococcus neoformans infection in France: epidemiologic features of and early prognostic parameters for 76 patients who were infected with human immunodeficiency virus. Clin Infect Dis 1996, 23:369-376.
12. Diamond R.D. Cryptococcus neoformans. Principles and practice of infectious diseases 1995, 2331-2340. Churchill Livingstone, New York. 4th ed. G.L. Mandell, R.G. Douglas, J.E. Bennett (Eds.).
13. Dzoyem J.P., Kechia F.A., Ngaba G.P., Lunga P.K., Lohoue P.J. Prevalence of cryptococcosis among HIV-infected patients in Yaounde. Cameroon Afr Health Sci 2012, 12:129-133.
14. Ennis D.M., Saag M.S. Cryptococcal meningitis in AIDS. Hosp Pract 1993, 28:99-112.
15. Heyderman R.S., Gangaidzo I.T., Hakim J.G., Mielke J., Taziwa A., et al. Cryptococcal meningitis in human immunodeficiency virus-infected patients in Harare. Zimbabwe Clin Infect Dis 2001, 32:1235-1236.
16. Homa A.-B. Infections opportunistes chez le patient immunodéprimé. Bull Div Fr AIP 2007, 46.
17. Jain N., Cook E., Xess I., Hasan F., Fries D., Fries B.C. Isolation and characterization of senescent Cryptococcus neoformans and implications for phenotypic switching and pathogenesis in chronic cryptococcosis. Am Soc Microbiol 2009, 8:858-866.
18. Jin Qiu, Olszewski M.A., Williamson P.R. Cryptococcus neoformans growth and protection from innate immunity are dependent on expression of a virulence-associated DEAD-Box protein. Vad1 Infect Immun 2013, 81:777-788. 10.1128/IAI. 00821-12.
19. Kathleen J.M., Nelesh P.G., Jenny R., Meiring S., Mitchell T.G. Respiratory, and meningeal disease surveillance in South Africa. Analyses of pediatric isolates of Cryptococcus neoformans from South Africa. J Clin Microbiol 2011, 49:307-314. the Group for Enteric. 10.1128/JCM.01277-10.
20. Lee C.-H., Chang T.-Y., Liu J.-W., Chen F.-J., Chien C.-C., Tang Y.-F., et al. Correlation of anti-fungal susceptibility with clinical outcomes in patients with cryptococcal meningitis. BMC Infect Dis 2012, 12:361. 10.1186/1471-2334-12-361.
21. Maslin J., Morand J.-J., Menard G., Camparo P. Les cryptococcoses. Med Trop 2002, 62:480-484.
22. Mbuagbaw J.N., Biholong, Njamnshi A.K. La Cryptococcose Neuro-Méningée et l'infection au VIH dans le service de médecine du Centre Hospitalier et Universitaire de Yaoundé. Cameroun Af J Neu Sces 2006, 25:13-20.
23. McClelland E.E., Hobbs L.M., Rivera J., Casadevall A., Potts W.K., Smith J.M., et al. The role of host gender in the pathogenesis of Cryptococcus neoformans infections. PLoS One 2013, 8:e63632. 10.1371/journal.pone.0063632.
24. Millogo A., Ki-Zerbo G.-A., Andonaba J.B., Lankoandé D., Sawadogo A., Yaméogo I., et al. La cryptococcose neuroméningée au cours de l'infection par le VIH au centre hospitalier de Bobo-Dioulasso (Burkina Faso). Bull Soc Pathol Exo 2004, 97:119-121.
25. Nelesh G. HIV-associated opportunistic fungal infections: a guide to using the clinical microbiology laboratory. The S Af J of HIV med 2007, 1:18-23.
26. O'Meara T.R., Holmer S.M., Alspaugh J.A. Cryptococcus neoformans Is associated with cell wall remodelling and evasion of the host immune responses. mBio 2013, 4:e00522-12.
27. ONUSIDA Le point sur l'épidémie de SIDA: Genève 2005 2005, http://www.unaids.org/.
28. ONUSIDA Diapositives clés sur les données épidémiologiques 2012, http://www.unaids.org/.
29. Oumar A.A., Dao S., Diallo S., Kaba M.K., Ciss I.A., Tounkara A. Prévalence des infections opportunistes au cours du Sida en milieu hospitalier de Bamako, Mali. Bull Soc Pathol Exot 2008, 127:12-17.
30. Park B.J., Wannemuehler K.A., Marston B.J., Govender N., Pappas P.G., Chiller T.M. Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. AIDS 2009, 23:525-530.
31. Prasad K.N., Agarwal J., Nag V.L., Verma A.K., Dixit A.K., Ayyagari A. Cryptococcal infection in patients with clinically diagnosed meningitis in a tertiary care center. Neurol Ind 2003, 51:364-366.
32. Rozenbaum R., Goncalves A.J. Clinical epidemiological study of 171 cases of cryptococcosis. Clin Infect Dis 1994, 18:369-380.
33. Saha D.C., Xess I., Biswas A., Bhowmik D.M., Padma M.V. Detection of Cryptococcus by conventional, serological and molecular methods. J Med Microbiol 2009, 58:1098-1105.
34. Saldanha D.R.M., Prashanth H.V., Shenoy S., Baliga S. Diagnostic value of latex agglutination in cryptococcal meningitis. J Lab Physicians 2009, 1:67-68. 10.4103/0974-2727.59702.
35. Sivasangeetha K., Harish B.N., Sujatha S., Parija S.C., Dutta T.K. Cryptococcal meningoencephalitis diagnosed by blood culture. Ind J Med Microbiol 2007, 25:282-284.
36. Soumaré M., Seydi M., Ndour C.T., Dieng Y., Diouf A.M., Diop B.M. Aspects actuels de la cryptococcose neuro-meningée à Dakar. Med Trop 2005, 65:559-562.
37. Stoeckli T.C., Burman W.J. Inactivated pronase as the cause of false-positive results of serum cryptococcal antigen tests. Clin Infect Dis 2001, 32:836-837.
38. Sukroongreung S., Eampokalap B., Tansuphaswadikul S., Nilakul C., Tantimavanich S. Recovery of Cryptococcus neoformans from the nasopharynx of AIDS patients. Mycopathologia 1998, 143:131-134.
39. Tanner D.C., Weinstein M.P., Fedorciw B., Joho K.L., Thorpe J.J., Reller L. Comparison of commercial kits for detection of cryptococcal antigen. J Clin Microbiol 1994, 32:1680-1684.
40. Yassibanda S., Kamalo C.G., Mbolidi C.D., et al. Les infections neuro-méningées de l'adulte en milieu hospitalier à Bangui: aspects étiologiques, cliniques et évolutifs. Med Afr Noir 2002, 49:299-303.